-
levothyroxine (Synthroid) 75mcg 1 tab PO
*hormone- thyroid preperation
*restores normal hormonal balance
*increases metabolic rate of body tissue
*stims protein synthesis
- side effects:
- hyperthroidism, insomnia, ab cramps, tachycardia, sweating, irregular menstration, weight loss
- implications:
- *assess BP and apical
- *monitor thyroid function studies
-
rivastigmine (Exelon) 9.5 mg 1 patch
*anti-Alzheimer's drug
*cholinesterase inhibitor
*enhanced cholinergic function to decrease dementia
- side effects:
- weakness, anorexia, nausea, vomitting, diarrhea, headache, edema, tremor
- implications:
- *assess cognitive function throughout therapy
- *monitor for nausea, vomitting, anorexia or weight loss
- *may be worn during bathing/hot weather
-
memantine (Namenda) 5mg 1 tab PO
*anti-Alzheimer's
*prevents binding of excititory neirotransmitter glutamate
*cognitive enhancement
- side effects:
- dizziness, fatigue, headache, sedation, hypertension, diarrhea, weight gain, anemia
- implications:
- *assess cognitive abilities periodically
- *monitor for anemia
-
Aggrenox 25-200mg 1 cap PO
- combo drug
- *asprin 25 mg
- *extended release dipyridamole 200 mg
-
asprin 25 mg
*non-steroidal anti-inflammatory (NSAID)
*antipyretic
*non opiod analgesic
*inhibits prostoglandin synthesis re: pain/inflammation
*causes vasodilation
*anticoagulant (decreased platlet aggregation)
side effects: gastric discomfort/bleeding, anemia, increased bleeding time, allergic reaction
implications:
*prolonged bleeding and prothrombin time
*monitor hematocrit to assess for GI blood loss
*increased risk for gastric ulcers
- dipyridamole 200 mg
- *antiplatelet agent
- *coronary vasodilator
- side effects:
- dizziness, headache, syncope, nausea, GI upset
*Beer's List- monitor for orthostatic hypotension in geriatric clients
-
acetaminophen 325 mg 2 tabs PO
*antipyretic
*non opiod analgesic (mild to moderate pain)
*inhibits prostaglandin synthesis
- side effects:
- hepatotoxicity, constipation, renal failure in high doses
- implications:
- *assess for malnourishment/alcohol use before beginning treatment (increases risk of hepatotoxicity)
- *monitor hepatic, hematologic and renal function periodically
|
|
